Latest Stem Cells news
FDA Approves Darzalex Faspro for Treating Multiple Myeloma
posted August 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Socioeconomic Status of Stem Cell Donor Affects Recipient Health Outcomes
posted July 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Successful Pregnancy Possible for Stem Cell Transplant Recipients
posted July 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Posttransplant Cyclophosphamide GVHD Prophylaxis Beneficial in Leukemia
posted June 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally 
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race 
Mental Distress, Fatigue Common in Childhood Survivors of Leukemia, Lymphoma Related Articles
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy 
Guidelines Issued for Management of Acute Lymphoblastic Leukemia in Teens, Young Adults Monthly Specialist Briefings
Stay Connected
